These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26590387)

  • 21. Mitochondrial metals as a potential therapeutic target in neurodegeneration.
    Grubman A; White AR; Liddell JR
    Br J Pharmacol; 2014 Apr; 171(8):2159-73. PubMed ID: 24206195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?
    Chan F; Lax NZ; Davies CH; Turnbull DM; Cunningham MO
    Neuropharmacology; 2016 Mar; 102():48-58. PubMed ID: 26518370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial transplant to replenish damaged mitochondria: A novel therapeutic strategy for neurodegenerative diseases?
    Mukherjee A; Becerra Calixto AD; Chavez M; Delgado JP; Soto C
    Prog Mol Biol Transl Sci; 2021; 177():49-63. PubMed ID: 33453942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial pharmacology.
    Smith RA; Hartley RC; Cochemé HM; Murphy MP
    Trends Pharmacol Sci; 2012 Jun; 33(6):341-52. PubMed ID: 22521106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials in mitochondrial disorders, an update.
    Almannai M; El-Hattab AW; Ali M; Soler-Alfonso C; Scaglia F
    Mol Genet Metab; 2020; 131(1-2):1-13. PubMed ID: 33129691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitophagy in neurodegeneration: an opportunity for therapy?
    Santos RX; Correia SC; Carvalho C; Cardoso S; Santos MS; Moreira PI
    Curr Drug Targets; 2011 Jun; 12(6):790-9. PubMed ID: 21269269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.
    Komen JC; Thorburn DR
    Br J Pharmacol; 2014 Apr; 171(8):1818-36. PubMed ID: 24102298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeutics.
    Foriel S; Willems P; Smeitink J; Schenck A; Beyrath J
    Int J Biochem Cell Biol; 2015 Jun; 63():60-5. PubMed ID: 25666557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
    Wilkins HM; Morris JK
    Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases.
    Johnson J; Mercado-Ayon E; Mercado-Ayon Y; Dong YN; Halawani S; Ngaba L; Lynch DR
    Arch Biochem Biophys; 2021 May; 702():108698. PubMed ID: 33259796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological modulation of mitochondrial calcium homeostasis.
    Arduino DM; Perocchi F
    J Physiol; 2018 Jul; 596(14):2717-2733. PubMed ID: 29319185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial pharmacology: energy, injury and beyond.
    Davidson SM; Lopaschuk GD; Spedding M; Beart PM
    Br J Pharmacol; 2014 Apr; 171(8):1795-7. PubMed ID: 24684388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.
    Uittenbogaard M; Chiaramello A
    Mol Genet Metab; 2020; 131(1-2):38-52. PubMed ID: 32624334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model.
    Fox BC; Slade L; Torregrossa R; Pacitti D; Szabo C; Etheridge T; Whiteman M
    J Inherit Metab Dis; 2021 Mar; 44(2):367-375. PubMed ID: 33325042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for treating mitochondrial disorders: an update.
    Scarpelli M; Todeschini A; Rinaldi F; Rota S; Padovani A; Filosto M
    Mol Genet Metab; 2014 Dec; 113(4):253-60. PubMed ID: 25458518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.
    Liu J; Wang LN
    CNS Drugs; 2014 Jan; 28(1):63-8. PubMed ID: 24242074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling and Regulation of the Mitochondrial Unfolded Protein Response.
    Naresh NU; Haynes CM
    Cold Spring Harb Perspect Biol; 2019 Jun; 11(6):. PubMed ID: 30617048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.
    Adhihetty PJ; Beal MF
    Neuromolecular Med; 2008; 10(4):275-90. PubMed ID: 19005780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.